IEQ Capital’s Indivior Pharmaceuticals INDV Stock Holding History

IEQ Capital’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,468	Closed	-$806K	–	1987
2025 Q4	$806K	Buy	+22,468	New	+$686K	﹤0.01%	1125

Other funds holding INDV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

IEQ Capital's INDV Position: Q1 2026 in Review

IEQ Capital sold out of Indivior Pharmaceuticals (INDV) in Q1 2026, closing a stake of 22,468 shares — an estimated $806K sold.

IEQ Capital first reported a position in INDV in Q4 2025 and held it in 1 quarter. The position peaked at $806K in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

IEQ Capital reported no remaining Indivior Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
IEQ Capital sold 22,468 Indivior Pharmaceuticals shares in Q1 2026, an estimated $806K.
IEQ Capital first reported a position in Indivior Pharmaceuticals in Q4 2025 and held it in 1 quarter.
IEQ Capital's Indivior Pharmaceuticals position peaked at $806K in Q4 2025.
289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.